NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research

        • Research Overview
        • Clinical Research Facility
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient & Public Involvement
    • Getting involved with research
    • View and register for involvement opportunities
    • Patient & Public Groups
    • Patient and Public Involvement Advisory Group
    • Diversity in Research Group
    • Oxford Blood Group
    • Case Studies
    • PPIE Strategy
    • PPIE News
    • PPI Researcher Guidance
    • Researchers: Post a PPIE opportunity
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events
Research Theme

Life-saving Vaccines

You are here: Home > News > News for Life-saving Vaccines

News for Life-saving Vaccines

Oxford COVID-19 vaccinations begin

4 January 2021 · Listed under COVID-19, Life-saving Vaccines

The NHS has launched the roll-out of the new Oxford AstraZeneca coronavirus vaccine, with patients at Oxford University Hospitals NHS Foundation Trust (OUH) the very first to get the life-saving jab. Among the first to be vaccinated was Prof Andrew Pollard, the Oxford BRC investigator who has ... READ MORE

Key step for hepatitis research as patient database created

10 December 2020 · Listed under Life-saving Vaccines, Translational Data Science

For the first time, a comprehensive database comprising an initial cohort of more than 1,300 patients with chronic hepatitis B or hepatitis C infections has been developed for potential future research into the conditions. The methodology to develop a pipeline to collect and manage this data ... READ MORE

Peer-reviewed results of phase 3 Oxford coronavirus vaccine trial demonstrate efficacy

8 December 2020 · Listed under COVID-19, Life-saving Vaccines

The vaccine against SARS-CoV-2 developed by researchers from the University of Oxford and AstraZeneca is safe and effective according to the peer-reviewed findings of the phase 3 trial. The pooled analysis of the trial across two different dose regimens resulted in an average efficacy of 70.4%; ... READ MORE

Oxford University breakthrough on global COVID-19 vaccine

23 November 2020 · Listed under COVID-19, Life-saving Vaccines

The University of Oxford, in collaboration with AstraZeneca plc, has announced interim trial data from its Phase III trials that shows its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 and offers a high level of protection. The interim analysis indicates that the ... READ MORE

Health economists outline possible criteria for allocating COVID-19 vaccine

3 September 2020 · Listed under Life-saving Vaccines

NIHR Oxford BRC-supported health economics researchers have published a paper outlining the possible criteria that governments might use to prioritise who gets a COVID-19 vaccine once one has been approved for use. The article - ‘How Should a Safe and Effective COVID-19 Vaccine be Allocated? ... READ MORE

BRC researchers’ work recognised with Vice-Chancellor’s Awards

30 July 2020 · Listed under Life-saving Vaccines, Molecular Diagnostics, Surgical Innovation, Technology and Evaluation

A number of Oxford BRC-supported researchers have been recognised in this year’s University of Oxford Vice-Chancellor Innovation Awards. The Vice-Chancellor Innovation Awards celebrate research-led innovation that is having societal or economic impact. Prof Robert MacLaren, who leads the BRC’s ... READ MORE

Oxford coronavirus vaccine produces strong immune response, study finds

20 July 2020 · Listed under Life-saving Vaccines

A team of scientists at Oxford University’s Jenner Institute and Oxford Vaccine Group has taken the next step towards the discovery of a safe, effective and accessible vaccine against coronavirus. The results of the Phase I/II trial, published today in The Lancet, indicate no early safety ... READ MORE

Oxford COVID-19 vaccine to begin phase II/III human trials

22 May 2020 · Listed under COVID-19, Life-saving Vaccines

University of Oxford researchers have begun recruiting for the next phase in human trials of a COVID-19 vaccine in human volunteers. The phase I trial in healthy adult volunteers began in April. More than 1,000 immunisations have been completed and follow-up is currently ongoing. The next ... READ MORE

Oxford COVID-19 vaccine begins human trial stage

23 April 2020 · Listed under COVID-19, Life-saving Vaccines

University of Oxford researchers have begun testing a COVID-19 vaccine in human volunteers in Oxford. Around 1,110 people will take part in the trial, half receiving the vaccine and the other half (the control group) receiving a widely available meningitis vaccine. Of the first two ... READ MORE

BRC funds three further COVID-19 studies

21 April 2020 · Listed under COVID-19, Gene and Cell Therapy, Inflammation across Tissues, Life-saving Vaccines

Three more studies are being funded by the NIHR Oxford Biomedical Research Centre (BRC) to look at the way the body interacts with COVID19; these include assessing the safety of a new vaccine; the role that antibodies might play in plasma therapy; and blood biomarkers that determine adverse ... READ MORE

Oxford COVID-19 vaccine programme opens for clinical trial recruitment

27 March 2020 · Listed under COVID-19, Life-saving Vaccines

University of Oxford researchers, working in an unprecedented vaccine development effort to prevent COVID-19, have started screening healthy volunteers ahead of a vaccine trial. The NIHR Oxford Biomedical Research Centre (BRC) provided essential funding to get the trial up and running. The ... READ MORE

Oxford researchers to play key role in fight-back against COVID-19

20 March 2020 · Listed under COVID-19, Inflammation across Tissues, Life-saving Vaccines, Modernising Medical Microbiology and Big Infection Diagnostics, Partnerships for Health, Wealth and Innovation, Respiratory Medicine, Translational Data Science

Researchers supported by the NIHR Oxford Biomedical Research Centre will play a crucial role in tackling the current COVID-19 pandemic, ranging from the development of a new vaccine to developing the most effective drug treatments for people who have contracted the virus. A team from the ... READ MORE

Working together to find a cure to HIV

21 February 2020 · Listed under Life-saving Vaccines

Results from a study testing a new ‘kick and kill’ method of reducing the size of the undetected HIV reservoir in people living with the virus were published in The Lancet this week. RIVER (Research in Viral Eradication of HIV Reservoirs) is the first ever randomised clinical trial to test this ... READ MORE

Successful Nepal study for typhoid vaccine developed in Oxford

13 December 2019 · Listed under Life-saving Vaccines

A large field study in Nepal has shown that a typhoid conjugate vaccine (TCV) developed in Oxford is over 81 percent effective in tackling the disease. A single dose of the vaccine was found to be safe and effective in reducing typhoid in children aged 9 months to 16 years in an endemic ... READ MORE

NIHR Oxford BRC Senior Research Fellows named

14 May 2019 · Listed under Life-saving Vaccines, Modernising Medical Microbiology and Big Infection Diagnostics, Multimorbidity and Long-Term Conditions, Musculoskeletal, Other News, Preventive Neurology, Respiratory Medicine, Translational Data Science

The Oxford BRC is delighted to announce the appointment of seven new Senior Research Fellows. They were chosen from an extremely strong field of 47 applicants from across the scientific and clinical community because they demonstrated that their research was high impact and of high quality . ... READ MORE

BRC researchers elected Fellows of Academy of Medical Sciences

8 May 2019 · Listed under Inflammation across Tissues, Life-saving Vaccines, Modernising Medical Microbiology and Big Infection Diagnostics

Three Oxford BRC-supported researchers are among eight University of Oxford scientists elected to join the prestigious Fellowship of the Academy of Medical Sciences (AMS) this year. The BRC researchers among the new Fellows are: Professor Helen McShane, Professor of Vaccinology in the ... READ MORE

Oxford medical researchers win prestigious national awards

14 March 2019 · Listed under Life-saving Vaccines, Modernising Medical Microbiology and Big Infection Diagnostics, Multimorbidity and Long-Term Conditions, Musculoskeletal, Preventive Neurology, Respiratory Medicine

Four leading healthcare academics in Oxford have received a prestigious national award. The University of Oxford professors have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their “outstanding contribution to clinical and applied ... READ MORE

HIV remission achieved in second patient

5 March 2019 · Listed under Life-saving Vaccines

A second person has experienced sustained remission from HIV-1 after ceasing treatment, ten years after the first such case. The case was reported in a paper to be published in Nature. Like the first such case, known as the ‘Berlin Patient’, the second patient was treated with stem ... READ MORE

Oxford medical researchers win prestigious national awards

23 February 2018 · Listed under Gene and Cell Therapy, Inflammation across Tissues, Life-saving Vaccines, Metabolic Experimental Medicine, Modernising Medical Microbiology and Big Infection Diagnostics, Obesity, Diet and Lifestyle, Partnerships for Health, Wealth and Innovation, Preventive Neurology, Surgical Innovation, Technology and Evaluation

Leading health researchers in Oxford have been recognised in a prestigious national competition. Eight professors have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their “outstanding contribution to clinical and applied health and social care ... READ MORE

World-first NHS trial for universal flu vaccine

3 October 2017 · Listed under Life-saving Vaccines

The world’s first widespread human testing of a flu vaccine which NIHR Oxford BRC researchers hope will protect more over 65-year-olds against influenza has begun in the NHS. More than 10,000 people aged 65 and over will be asked to take part in a study supported by the National Institute for ... READ MORE

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Life-saving Vaccines

  • Life-saving Vaccines
  • Sub-theme 1: Outbreak pathogens
  • Sub-theme 2: Enteric vaccines
  • Sub-theme 3: ‘The big three’ – TB, malaria and HIV
  • Sub-theme 4: Childhood / pregnancy / perinatal vaccines
  • Sub-theme 5: Vaccines in chronic disease and ageing
  • Contacts
  • Videos
  • News

Other News

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre